NCT00110604View on ClinicalTrials.gov

The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing

NACompletedINTERVENTIONAL
Enrollment

835

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

December 31, 2004

Conditions
AtherosclerosisVascular DiseaseCognitive DeclineHearing LossInflammationAge-Related Memory Disorder
Interventions
BEHAVIORAL

folic acid (0.8 mg)

Trial Locations (1)

6700 EV

Wageningen University, Wageningen

All Listed Sponsors
collaborator

Wageningen Centre for Food Sciences

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Wageningen University

OTHER

NCT00110604 - The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing | Biotech Hunter | Biotech Hunter